Drug – bio-affecting and body treating compositions – Lymphokine
Reexamination Certificate
2005-05-17
2005-05-17
Brumback, Brenda (Department: 1646)
Drug, bio-affecting and body treating compositions
Lymphokine
C424S094400, C514S400000, C514S419000, C514S458000, C514S474000, C514S725000
Reexamination Certificate
active
06893633
ABSTRACT:
Disclosed is a method of promoting the maturation of monocytes comprising the administration of a reactive oxygen species (ROS) inhibitor or scavenger and at least one monocyte maturation-promoting agent. A composition for promoting the maturation of monocytes is likewise disclosed. The pharmaceutical composition includes a compound effective to promote the maturation of monocytes and a ROS inhibitor or scavenger combined in a pharmaceutically acceptable carrier.
REFERENCES:
patent: 5702697 (1997-12-01), Zimmerman et al.
patent: 5849589 (1998-12-01), Tedder et al.
patent: 0 808 897 (1997-11-01), None
patent: WO-9605289 (1996-02-01), None
patent: WO-9742968 (1997-11-01), None
patent: 9951257 (1999-10-01), None
patent: 0010600 (2000-03-01), None
patent: 0040240 (2000-07-01), None
Hellstrand et al. (2001) Up-regulation of the CD86 co-stimulatory antigen on human monocytes by combined treatment with histamine dihydrochloride and granulocyte-macrophage colony-stimulating factor (GM-CSF). 42:330. XP-001069964.
Courtesy copy of PCT International Search Report dated May 14, 2002 in 2 pages.
Avigan, D. (1999) Dendritic cells: development, function and potential use for cancer immunotherapy. Blood Reviews. 13:51-64.
Bell et al. (1999) Dendritic cells. Advances in Immunology. 72:255-324.
Croft et al. (1997) Accessory molecule and costimulation requirements for CD4 T cell response. Critical Reviews in Immunology. 17:89-118.
Gieseler et al. (1998) In-Vitro differentiation of mature dendritic cells from human blood monocytes. Developmental Immunology. 6:25-39.
Hellstrand et al. (1994) Histaminergic regulation of NK cells. The Journal of Immunology. 153:4940-4947.
Kiertscher et al. (1996) Human CD14+ leukocytes acquire the phenotype and function of antigen-presenting dendritic cells when cultured in GM-CSF and IL-4. Journal of Leukocyte Biology. 59:208-218.
Lawson et al. (2000) Granulocyte-macrophage colony-stimulating factor: another cytokine with adjuvant therapeutic benefit in melanoma? Journal of Clinical Oncology. 18(8):1603-1605.
McCoy et al. (1999) The role of CTLA-4 in the regulation of T cell immune responses. Immunology and Cell Biology. 77:1-10.
Slavik et al. (1999) CD2/CTLA-4 and CD80/CD86 Families. Immunologic Research. 19(1):1-24.
Spitler et al. (2000) Adjuvant therapy of stage III and IV mallignant melanoma using granulocyte-macrophage colony-stimulating factor. Journal of clinical Oncology. 18(8):1614-1621.
Gehlsen Kurt R.
Hellstrand Kristoffer
Hermodsson Svante H.
Brumback Brenda
Knobb Martens Olson & Bear LLP
Li Ruixiang
Maxim Pharmaceuticals, Inc.
LandOfFree
Methods and compositions for promoting the maturation of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for promoting the maturation of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for promoting the maturation of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3460260